Health Care & Life Sciences » Biotechnology | Chongqing Zhifei Biological Products Co. Ltd.

Chongqing Zhifei Biological Products Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
130,347.80
148,004.00
197,401.90
32,520.30
432,275.40
1,451
Depreciation, Depletion & Amortization
27,270.70
34,880.30
41,503.40
55,500.70
63,894.90
91
Other Funds
81,996.40
12,193.00
22,944.80
105,625.50
109,618.10
76
Funds from Operations
181,583.40
194,722.80
239,582.20
117,311.40
544,321.70
1,604
Changes in Working Capital
39,992.80
33,769.20
19,088.30
27,356.50
348,176.60
1,045
Net Operating Cash Flow
221,576.20
160,953.60
220,493.90
89,954.90
196,145.10
559
Capital Expenditures
201,366.00
276,955.50
225,715.10
308,047.00
215,540.70
Sale of Fixed Assets & Businesses
34.20
47.80
176.50
230.70
191.60
Purchase/Sale of Investments
914,231.30
10,000.00
4,000.00
106,000.00
20,000.00
Net Investing Cash Flow
198,100.40
336,907.70
221,538.60
151,776.30
235,349.00
Cash Dividends Paid - Total
-
80,000.00
80,000.00
80,000.00
16,000.00
Issuance/Reduction of Debt, Net
-
54,375.50
54,375.50
-
260,000.00
Net Financing Cash Flow
81,996.40
13,431.50
210,938.50
25,625.50
134,381.90
Net Change in Cash
58,520.70
189,385.50
211,983.20
35,596.70
93,479.20
Free Cash Flow
20,210.20
116,001.90
5,221.20
218,092.10
19,395.60
Deferred Taxes & Investment Tax Credit
14,118.80
1,083.50
6,921.80
10,739.20
1,450.10
14
Other Sources
-
-
-
50,040.00
-
Change in Capital Stock
-
-
99,507.80
-
-
Exchange Rate Effect
-
-
-
599.20
1,698.70
Other Uses
911,000.00
50,000.00
-
-
-

About Chongqing Zhifei Biological Products Co.

View Profile
Address
25th floor, 7 Jinyuan Road
Chongqing Chongqing 400020
China
Employees -
Website http://www.zhifeishengwu.com
Updated 07/08/2019
Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. Its main products are meningococcal group A&C conjugate vaccine, meningococcal polysaccharide vaccine, mycobacterium vaccae, Haemophilus Influenzae type b conjugate vaccine, and freeze-dried live attenuated hepatitis A vaccine. Its other activities are biotechnology research, development, and consulting; import and export, and storage services.